Holen Sie sich die Stockscreener-App
5.29
0.00%
0.00
Third Harmonic Bio Inc Aktie (THRD) Neueste Nachrichten
Fierce Biotech Layoff Tracker 2025: Rapt reduces workforce; Plexium pares down staff - Fierce Biotech
Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace
Third Harmonic Bio Reports Q1 2025 Financial Results - TipRanks
Cancer drugmaker iTeos to shut down - BioPharma Dive
It’s been three months without a biotech IPO - Endpoints News
THIRD HARMONIC BIO Earnings Results: $THRD Reports Quarterly Earnings - Nasdaq
Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Third Harmonic Bio Announces Plan of Liquidation and Dissolution - ADVFN
Here’s Why Third Harmonic Bio (THRD) Fell in Q1 - Insider Monkey
Acelyrin should liquidate instead of merging with Alumis, investor says - BioPharma Dive
Third Harmonic Bio’s CSO Christopher Dinsmore Steps Down - MSN
Third Harmonic Bio CSO steps down, enters separation agreement - Investing.com Australia
Third Harmonic Bio CSO steps down, enters separation agreement By Investing.com - Investing.com India
Dupixent bounces back in treating hives with FDA approval - BioWorld MedTech
New fund Alis offers struggling biotechs an off-ramp: Finance Report - BioCentury
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
SF biotech company, once worth nearly $1 billion, plans to shut down - SFGATE
Biotech Alert: Searches spiking for these stocks today - TipRanks
Third Harmonic Bio (THRD) Plans Liquidation; Significant Search Surge in Biotech Sector | ARTL Stock News - GuruFocus
Third Harmonic Bio (THRD) Seeks Stockholder Approval for Liquida - GuruFocus
Third Harmonic Bio plans to liquidate the company, sell urticaria treatment - MSN
Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties - TipRanks
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Third Harmonic Bio leaps as it reveals liquidation plan - The Pharma Letter
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered - MSN
$26bn Brighton Jones hires new CFO - Citywire
Third Harmonic Bio plans liquidation and asset sale By Investing.com - Investing.com South Africa
Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Higher In Monday's Pre-Market Session (CORRECTED) - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Third Harmonic outlines plans for dissolution - BioPharma Dive
Third Harmonic Bio sees initial distribution of $5.13-$5.33 from liquidation - TipRanks
Third Harmonic Bio stock holds as liquidation plan unveiled By Investing.com - Investing.com Canada
Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?Third Harmonic Bio (NASDAQ:THRD) - Benzinga
Third Harmonic Announces Liquidation And Cash Return, Stock Jumps - Nasdaq
Third Harmonic to shutter; Future Pak once again targets Theratechnologies - Endpoints News
THRD’s Ambitious Moves: From Trials to Strategies? - timothysykes.com
Third Harmonic Bio Plans Liquidation With Lucrative Payouts - Finimize
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Third Harmonic Bio announces plan of liquidation and dissolution - TipRanks
Third Harmonic Seeks to Liquidate, Dissolve Company - marketscreener.com
1.21%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):